Novel Anticancer Triple Formula Based on Aptamer-Conjugated PEGylated Nanoliposomes

Novel Anticancer Triple Formula Based on Aptamer-Conjugated PEGylated Nanoliposomes

Background Cancer remains a leading cause of death worldwide, necessitating the development of affordable and innovative therapies to reduce its human and economic burden. Objectives In this study, we aimed to develop a synergistic anticancer formula encapsulated in nanoliposomes to enhance efficacy...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Al-Samydai PhD, Hamdi Nsairat PhD, Moath Alqaraleh PhD, Maha N. Abu Hajleh PhD, Areej Jaber PhD, Lidia Al-Halaseh PhD, Hanan Azzam MS, Qasim Khalid Alazzawi PhD, Israa Al-Ani PhD, Simone Carradori PhD, Walhan Alshaer PhD
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338251356548
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://doi.org/10.1177/15330338251356548

Similar Items